Moderna, Inc. (MRNA) FY2026 Q1 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-03-31

Swipe to see the full flow
Moderna, Inc. (MRNA) FY2026 Q1 Balance SheetBalance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.Current liabilities$2.40 BLiabilities$4.08 BCurrent assets$5.77 BAssets$11.49 BNon-current liabilities$1.69 BNon-current assets$5.72 BEquity$7.41 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInvestmentsCash and cash equivalentsPrepaid expenses and other current assetsInventoryAccounts receivable, netInvestments, non-currentProperty, plant and equipment, netRight-of-use assets, operating leasesOther non-current assetsAccrued liabilitiesOther current liabilitiesAccounts payableDeferred revenueOperating lease liabilities, non-currentLong-term debtOther non-current liabilitiesDeferred revenue, non-currentFinancing lease liabilities, non-currentRetained earningsAdditional paid-in capitalAccumulated other comprehensive incomeCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityCurrent liabilitiesCurrent liabilities$2.40 BAccrued liabilitiesAccrued liabilities$1.91 BOther current liabilitiesOther current liabilities$220.00 MLiabilitiesLiabilities$4.08 BCurrent assetsCurrent assets$5.77 BAccounts payableAccounts payable$161.00 MInvestmentsInvestments$3.30 BAssetsAssets$11.49 BDeferred revenueDeferred revenue$102.00 MCash and cash equivalentsCash and cash equivalents$1.91 BOperating lease liabilities, non-currentOperating lease liabilities, non-current$645.00 MNon-current liabilitiesNon-current liabilities$1.69 BPrepaid expenses and other current assetsPrepaid expenses and other current assets$348.00 MLong-term debtLong-term debt$590.00 MInventoryInventory$146.00 MOther non-current liabilitiesOther non-current liabilities$283.00 MAccounts receivable, netAccounts receivable, net$71.00 MDeferred revenue, non-currentDeferred revenue, non-current$154.00 MNon-current assetsNon-current assets$5.72 BFinancing lease liabilities, non-currentFinancing lease liabilities, non-current$13.00 MEquityEquity$7.41 BInvestments, non-currentInvestments, non-current$2.25 BProperty, plant and equipment, netProperty, plant and equipment, net$2.09 BRetained earningsRetained earnings$5.88 BRight-of-use assets, operating leasesRight-of-use assets, operating leases$706.00 MOther non-current assetsOther non-current assets$675.00 MAdditional paid-in capitalAdditional paid-in capital$1.50 BAccumulated other comprehensive incomeAccumulated other comprehensive income$25.00 M
Chart details

Moderna, Inc. (MRNA) FY2026 Q1 Balance Sheet

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

Assets
11,488,000,000 US dollars
Current assets
5,770,000,000 US dollars
Non-current assets
5,718,000,000 US dollars
Liabilities
4,080,000,000 US dollars
Current liabilities
2,395,000,000 US dollars
Non-current liabilities
1,685,000,000 US dollars
Equity
7,408,000,000 US dollars
Investments
3,297,000,000 US dollars
Cash and cash equivalents
1,908,000,000 US dollars
Prepaid expenses and other current assets
348,000,000 US dollars
Inventory
146,000,000 US dollars
Accounts receivable, net
71,000,000 US dollars
Investments, non-current
2,251,000,000 US dollars
Property, plant and equipment, net
2,086,000,000 US dollars
Right-of-use assets, operating leases
706,000,000 US dollars
Other non-current assets
675,000,000 US dollars
Accrued liabilities
1,912,000,000 US dollars
Other current liabilities
220,000,000 US dollars
Accounts payable
161,000,000 US dollars
Deferred revenue
102,000,000 US dollars
Operating lease liabilities, non-current
645,000,000 US dollars
Long-term debt
590,000,000 US dollars
Other non-current liabilities
283,000,000 US dollars
Deferred revenue, non-current
154,000,000 US dollars
Financing lease liabilities, non-current
13,000,000 US dollars
Retained earnings
5,880,000,000 US dollars
Additional paid-in capital
1,503,000,000 US dollars
Accumulated other comprehensive income
25,000,000 US dollars
Preferred stock, par value $0.0001; 162 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued or outstanding at March 31, 2026 and December 31, 2025
0 US dollars
Common stock, par value $0.0001; 1,600 shares authorized as of March 31, 2026 and December 31, 2025; 397 and 394 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
0 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Moderna, Inc. (MRNA) FY2026 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!